PLXPQ — PLx Pharma Winddown Share News
0.000.00%
Last trade - 00:00- $0.00m
- -$9.82m
- $8.21m
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice
U.S. STOCKS ON THE MOVE-Boeing, Carrier Global, Copper miners
U.S. STOCKS ON THE MOVE-Adaptimmune, Blink Charging, Silver miners
U.S. STOCKS ON THE MOVE-Regenxbio, Pear Therapeutics, Getty Images
U.S. STOCKS ON THE MOVE-Weight Watchers, ZeroFox, Innovative Eyewear
PLx Pharma slumps on Nasdaq notice for failing to comply with listing rule
Brief: PLx Pharma Says On April 4, Received Notice From Nasdaq That Co Had Not Regained Compliance With Listing Rule, Not Eligible For Second 180 Day Period
PLx Pharma Inc expected to post a loss of 28 cents a share - Earnings Preview
Protalix up as genetic disorder therapy inches closer to EC's approval
PLx Pharma Inc reports results for the quarter ended in September - Earnings Summary
Brief: PLx Pharma Inc. Reports Third Quarter 2022 Results And Provides Business Update
PLx Pharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: PLx Pharma Inc To Report Third Quarter 2022 Financial Results On November 11, 2022
Brief: PLx Pharma Says Received Non-Compliance Notice From Nasdaq
U.S. RESEARCH ROUNDUP- PLx pharma, Vroom, Walmart
PLx Pharma Inc reports results for the quarter ended in June - Earnings Summary